Why Intellia Therapeutics Was a Winner on Wednesday

Mere days after enjoying a major stock price pop, Intellia Therapeutics (NASDAQ: NTLA) had another good day on Wednesday. The gene-editing specialist's shares closed almost 7% higher on news of its latest capital-raising move.

Intellia announced after market close on Tuesday that it is floating a public offering of nearly 4.14 million shares of its common stock. These are to be priced at $145 per share. The issue's underwriters have been granted a 30-day option to buy up to an additional 620,689 shares.

Intellia said the offering should close on or about this Friday, July 2.

Continue reading

Source Fool.com